FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jukka Jolkkonen

Research Profile

Living Beings

Disorders

Physiology

Activities & Behaviors

Anatomy

Chemicals & Drugs

Concepts & Ideas

Co-author Network

Publications

TOP 3
Francisco J Ortega; Jukka Jolkkonen
Restorative therapies to enhance sensorimotor recovery following cerebral ischemia.
Anu Lipsanen; Manfred Windisch; Kristina Kuptsova; Stefanie Flunkert; Mikko Hiltunen; Birgit Hutter-Paier; Jukka Jolkkonen
Non-selective calcium channel blocker bepridil decreases secondary pathology in mice after photothrombotic cortical lesion.
Saara Parkkinen; Ina Tarkka; Joanna Huttunen; Kristina Kuptsova; Francisco J Ortega; Jukka Jolkkonen
Gait impairment in a rat model of focal cerebral ischemia.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jukka Jolkkonen (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Francisco J Ortega; Jukka Jolkkonen
Restorative therapies to enhance sensorimotor recovery following cerebral ischemia.
Acta neurobiologiae experimentalis 2013;73(1):66-78.
2013: Anu Lipsanen; Manfred Windisch; Kristina Kuptsova; Stefanie Flunkert; Mikko Hiltunen; Birgit Hutter-Paier; Jukka Jolkkonen
Non-selective calcium channel blocker bepridil decreases secondary pathology in mice after photothrombotic cortical lesion.
PloS one 2013;8(3):e60235.
2013: Saara Parkkinen; Ina Tarkka; Joanna Huttunen; Kristina Kuptsova; Francisco J Ortega; Jukka Jolkkonen
Gait impairment in a rat model of focal cerebral ischemia.
Stroke research and treatment 2013;2013():410972.
2013: Lili Cui; Jukka Jolkkonen; Huiling Qu; Ting Xiao; Mei Zhao; Chuansheng Zhao
Stromal cell-derived factor-1 and its receptor CXCR4 in adult neurogenesis after cerebral ischemia.
Restorative neurology and neuroscience 2013;31(3):239-51.
2013: Bhimashankar Mitkari; Johanna Nystedt; Tuulia Huhtala; Erja Kerkelä; Matti Korhonen; Ville Mikkonen; Jukka Jolkkonen
Intra-arterial infusion of human bone marrow-derived mesenchymal stem cells results in transient localization in the brain after cerebral ischemia in rats.
Experimental neurology 2013;239():158-62.
2012: Timo Sarajärvi; Hilkka Soininen; Annakaisa Haapasalo; Jukka Jolkkonen; Anu Lipsanen; Petra Mäkinen; Sirpa Peräniemi; Mikko Hiltunen
Bepridil decreases Aβ and calcium levels in the thalamus after middle cerebral artery occlusion in rats.
Journal of cellular and molecular medicine 2012;16(11):2754-67.
2011: Nick M E A Hayward; Pavel Yanev; Annakaisa Haapasalo; Riitta Miettinen; Mikko Hiltunen; Olli H J Gröhn; Jukka Jolkkonen
Chronic hyperperfusion and angiogenesis follow subacute hypoperfusion in the thalamus of rats with focal cerebral ischemia.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 2011;31(4):1119-32.
2009: Anna Hicks; Timothy Schallert; Jukka Jolkkonen
Cell-based therapies and functional outcome in experimental stroke.
Cell stem cell 2009;5(2):139-40.
2009: Mikko Hiltunen; Petra Mäkinen; Sirpa Peräniemi; Juhani Sivenius; Thomas van Groen; Hilkka Soininen; Jukka Jolkkonen
Focal cerebral ischemia in rats alters APP processing and expression of Abeta peptide degrading enzymes in the thalamus.
Neurobiology of disease 2009;35(1):103-13.
2009: Anna U Hicks; Riikka S Lappalainen; Susanna Narkilahti; Riitta Suuronen; Dale Corbett; Juhani Sivenius; Outi Hovatta; Jukka Jolkkonen
Transplantation of human embryonic stem cell-derived neural precursor cells and enriched environment after cortical stroke in rats: cell survival and functional recovery.
The European journal of neuroscience 2009;29(3):562-74.
2009: Mikko Hiltunen; Thomas van Groen; Jukka Jolkkonen
Functional roles of amyloid-beta protein precursor and amyloid-beta peptides: evidence from experimental studies.
Journal of Alzheimer's disease : JAD 2009;18(2):401-12.
2009: Anna Hicks; Jukka Jolkkonen
Challenges and possibilities of intravascular cell therapy in stroke.
Acta neurobiologiae experimentalis 2009;69(1):1-11.
2008: Giedrius Kalesnykas; T Tuulos; Hannu Uusitalo; Jukka Jolkkonen
Neurodegeneration and cellular stress in the retina and optic nerve in rat cerebral ischemia and hypoperfusion models.
Neuroscience 2008;155(3):937-47.
2008: Riikka S Lappalainen; Susanna Narkilahti; Tuulia Huhtala; Timo Liimatainen; Tiina Suuronen; Ale Närvänen; Riitta Suuronen; Outi Hovatta; Jukka Jolkkonen
The SPECT imaging shows the accumulation of neural progenitor cells into internal organs after systemic administration in middle cerebral artery occlusion rats.
Neuroscience letters 2008;440(3):246-50.
2008: Susanna Mäkinen; Thomas van Groen; Jared Clarke; Anders Thornell; Dale Corbett; Mikko Hiltunen; Hilkka Soininen; Jukka Jolkkonen
Coaccumulation of calcium and beta-amyloid in the thalamus after transient middle cerebral artery occlusion in rats.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 2008;28(2):263-8.
2008: Chuan-Sheng Zhao; Sirpa Hartikainen; Timothy Schallert; Juhani Sivenius; Jukka Jolkkonen
CNS-active drugs in aging population at high risk of cerebrovascular events: evidence from preclinical and clinical studies.
Neuroscience and biobehavioral reviews 2008;32(1):56-71.
2007: Jukka Jolkkonen; Kimmo Jokivarsi; Teemu Laitinen; Olli H J Gröhn
Subacute hemorrhage and resolution of edema in Rose Bengal stroke model in rats coincides with improved sensorimotor functions.
Neuroscience letters 2007;428(2-3):99-102.
2007: Jared Clarke; Anders Thornell; Dale Corbett; Hilkka Soininen; Mikko Hiltunen; Jukka Jolkkonen
Overexpression of APP provides neuroprotection in the absence of functional benefit following middle cerebral artery occlusion in rats.
The European journal of neuroscience 2007;26(7):1845-52.
2007: Heli Karhunen; Zinayida Bezvenyuk; Jari Nissinen; Juhani Sivenius; Jukka Jolkkonen; Asla Pitkänen
Epileptogenesis after cortical photothrombotic brain lesion in rats.
Neuroscience 2007;148(1):314-24.
2007: A U Hicks; K Hewlett; Victoria Windle; Garry Chernenko; Michelle Ploughman; Jukka Jolkkonen; S Weiss; Dale Corbett
Enriched environment enhances transplanted subventricular zone stem cell migration and functional recovery after stroke.
Neuroscience 2007;146(1):31-40.
2007: Jaakko Parkkinen; Pauli Ojala; Jenni Niiranen; Jukka Jolkkonen
Molecular mechanisms underlying neuroprotective effects of albumin after ischemic stroke.
Stroke; a journal of cerebral circulation 2007;38(2):255; author reply 256.
2006: Susanna Mäkinen; Tuija Kekarainen; Johanna Nystedt; Timo Liimatainen; Tuulia Huhtala; Ale Närvänen; Jarmo Laine; Jukka Jolkkonen
Human umbilical cord blood cells do not improve sensorimotor or cognitive outcome following transient middle cerebral artery occlusion in rats.
Brain research 2006;1123(1):207-15.
2006: Leena Aho; Jukka Jolkkonen; Irina Alafuzoff
Beta-amyloid aggregation in human brains with cerebrovascular lesions.
Stroke; a journal of cerebral circulation 2006;37(12):2940-5.
2006: Heli Karhunen; Jari Nissinen; Juhani Sivenius; Jukka Jolkkonen; Asla Pitkänen
A long-term video-EEG and behavioral follow-up after endothelin-1 induced middle cerebral artery occlusion in rats.
Epilepsy research 2006;72(1):25-38.
2006: Anna Rissanen; Juhani Sivenius; Jukka Jolkkonen
Prolonged bihemispheric alterations in unfolded protein response related gene expression after experimental stroke.
Brain research 2006;1087(1):60-6.
2006: Johanna Nystedt; Susanna Mäkinen; Jarmo Laine; Jukka Jolkkonen
Human cord blood CD34+ cells and behavioral recovery following focal cerebral ischemia in rats.
Acta neurobiologiae experimentalis 2006;66(4):293-300.
2006: Riitta Sonninen; Tuomas Virtanen; Juhani Sivenius; Jukka Jolkkonen
Gene expression profiling in the hippocampus of rats subjected to focal cerebral ischemia and enriched environment housing.
Restorative neurology and neuroscience 2006;24(1):17-23.
2005: Heli Karhunen; Jukka Jolkkonen; Juhani Sivenius; Asla Pitkänen
Epileptogenesis after experimental focal cerebral ischemia.
Neurochemical research 2005;30(12):1529-42.
2005: Thomas van Groen; Kirsi Puurunen; Hanna-Mari Mäki; Juhani Sivenius; Jukka Jolkkonen
Transformation of diffuse beta-amyloid precursor protein and beta-amyloid deposits to plaques in the thalamus after transient occlusion of the middle cerebral artery in rats.
Stroke; a journal of cerebral circulation 2005;36(7):1551-6.
2005: Chuan-Sheng Zhao; Kirsi Puurunen; Timothy Schallert; Juhani Sivenius; Jukka Jolkkonen
Behavioral effects of photothrombotic ischemic cortical injury in aged rats treated with the sedative-hypnotic GABAergic drug zopiclone.
Behavioural brain research 2005;160(2):260-6.
2005: Chuan-Sheng Zhao; Kirsi Puurunen; Juhani Sivenius; Jukka Jolkkonen; Timothy Schallert
Psychotropic medication and stroke outcome.
The American journal of psychiatry 2005;162(5):1026-7; author reply 1027-8.
2005: Chuan-Sheng Zhao; Kirsi Puurunen; Timothy Schallert; Juhani Sivenius; Jukka Jolkkonen
Behavioral and histological effects of chronic antipsychotic and antidepressant drug treatment in aged rats with focal ischemic brain injury.
Behavioural brain research 2005;158(2):211-20.
2005: Chuan-Sheng Zhao; Kirsi Puurunen; Timothy Schallert; Juhani Sivenius; Jukka Jolkkonen
Effect of cholinergic medication, before and after focal photothrombotic ischemic cortical injury, on histological and functional outcome in aged and young adult rats.
Behavioural brain research 2005;156(1):85-94.
2005: Antti Sohlberg; Jukka Jolkkonen; Ulla Ruotsalainen; Jyrki T Kuikka
Imaging D2-receptors in quinolinic acid lesioned rat striatum with high resolution pinhole SPECT.
Nuklearmedizin. Nuclear medicine 2005;44(5):N43-5.
2004: Antti Sohlberg; Sanna Lensu; Jukka Jolkkonen; Leena Tuomisto; Ulla Ruotsalainen; Jyrki T Kuikka
Improving the quality of small animal brain pinhole SPECT imaging by Bayesian reconstruction.
European journal of nuclear medicine and molecular imaging 2004;31(7):986-94.
2004: Juhani Sivenius; Jukka Jolkkonen
[New evidence about the efficiency of rehabilitation after stroke].
Duodecim; lääketieteellinen aikakauskirja 2004;120(20):2369-71.
2004: Tuomas Virtanen; Jukka Jolkkonen; Juhani Sivenius
Re: External carotid artery territory ischemia impairs outcome in the endovascular filament model of middle cerebral artery occlusion in rats.
Stroke; a journal of cerebral circulation 2004;35(1):e9-10; author reply e9-10.
2003: Heli Karhunen; Asla Pitkänen; Tuomas Virtanen; Irina Gureviciene; Raimo Pussinen; Aarne Ylinen; Juhani Sivenius; Jari Nissinen; Jukka Jolkkonen
Long-term functional consequences of transient occlusion of the middle cerebral artery in rats: a 1-year follow-up of the development of epileptogenesis and memory impairment in relation to sensorimotor deficits.
Epilepsy research 2003;54(1):1-10.
2003: Heli Karhunen; Tuomas Virtanen; Timothy Schallert; Juhani Sivenius; Jukka Jolkkonen
Forelimb use after focal cerebral ischemia in rats treated with an alpha 2-adrenoceptor antagonist.
Pharmacology, biochemistry, and behavior 2003;74(3):663-9.
2003: Jukka Jolkkonen; Nicola Palamero Gallagher; Karl Zilles; Juhani Sivenius
Behavioral deficits and recovery following transient focal cerebral ischemia in rats: glutamatergic and GABAergic receptor densities.
Behavioural brain research 2003;138(2):187-200.
2002: Johanna Kuhmonen; Jouko Lukkarinen; Olli H J Gröhn; Jukka Jolkkonen; Juhani Sivenius
Diazepam does not reduce infarct size in rats subjected to transient occlusion of the middle cerebral artery when normothermia is maintained.
The Journal of pharmacy and pharmacology 2002;54(11):1565-9.
2002: Juhani Sivenius; Kirsi Puurunen; Ina Tarkka; Jukka Jolkkonen
[Rehabilitation possibilities for stroke patients in the future].
Duodecim; lääketieteellinen aikakauskirja 2002;118(24):2569-76.
2002: Alexandra Barbelivien; Jukka Jolkkonen; Edita Rutkauskaite; Jouni Sirviö; Juhani Sivenius
Differentially altered cerebral metabolism in ischemic rats by alpha2-adrenoceptor blockade and its relation to improved limb-placing reactions.
Neuropharmacology 2002;42(1):117-26.
2001: Kirsi Puurunen; Jukka Jolkkonen; Jouni Sirviö; Antti Haapalinna; Juhani Sivenius
An alpha(2)-adrenergic antagonist, atipamezole, facilitates behavioral recovery after focal cerebral ischemia in rats.
Neuropharmacology 2001;40(4):597-606.
2001: Kirsi Puurunen; Jari Koistinaho; Jouni Sirviö; Jukka Jolkkonen; Juhani Sivenius
Enriched-environment housing increases neuronal Fos-staining in the dentate gyrus after a water maze spatial learning task.
Neuropharmacology 2001;40(3):440-7.
2001: Kirsi Puurunen; Jukka Jolkkonen; Jouni Sirviö; Antti Haapalinna; Juhani Sivenius
Selegiline combined with enriched-environment housing attenuates spatial learning deficits following focal cerebral ischemia in rats.
Experimental neurology 2001;167(2):348-55.
2001: S Butovas; Jouko Lukkarinen; Tuomas Virtanen; Jukka Jolkkonen; Juhani Sivenius
Differential effect of the alpha2-adrenoceptor antagonist, atipamezole, in limb-placing task and skilled forepaw use following experimental stroke.
Restorative neurology and neuroscience 2001;18(4):143-51.
2000: Jukka Jolkkonen; Risto A Kauppinen; L Nyman; Antti Haapalinna; Juhani Sivenius
MAO-B inhibition by a single dose of l-deprenyl or lazabemide does not prevent neuronal damage following focal cerebral ischaemia in rats.
Pharmacology & toxicology 2000;87(5):242-5.
2000: Tommi Saarelainen; Jouko Lukkarinen; Susanna Koponen; Olli H J Gröhn; Jukka Jolkkonen; Eija Koponen; Annakaisa Haapasalo; Leena Alhonen; Garry Wong; Jari Koistinaho; Risto A Kauppinen; Eero Castrén
Transgenic mice overexpressing truncated trkB neurotrophin receptors in neurons show increased susceptibility to cortical injury after focal cerebral ischemia.
Molecular and cellular neurosciences 2000;16(2):87-96.
2000: Jukka Jolkkonen; Kirsi Puurunen; S Rantakömi; A Härkönen; Antti Haapalinna; Juhani Sivenius
Behavioral effects of the alpha(2)-adrenoceptor antagonist, atipamezole, after focal cerebral ischemia in rats.
European journal of pharmacology 2000;400(2-3):211-9.
2000: Johanna Kuhmonen; Jukka Jolkkonen; Antti Haapalinna; Juhani Sivenius
The neuroprotective effects of (-)deprenyl in the gerbil hippocampus following transient global ischemia.
Journal of neural transmission (Vienna, Austria : 1996) 2000;107(7):779-86.
1999: Jukka Jolkkonen; Kirsi Puurunen; Jari Koistinaho; Risto A Kauppinen; Antti Haapalinna; L Nieminen; Juhani Sivenius
Neuroprotection by the alpha2-adrenoceptor agonist, dexmedetomidine, in rat focal cerebral ischemia.
European journal of pharmacology 1999;372(1):31-6.
1999: Asla Pitkänen; Jukka Jolkkonen
Do GABAergic circuitries play a critical role in the regulation of seizure-induced neuronal damage and synaptic reorganization in the rat hippocampus?
Electroencephalography and clinical neurophysiology. Supplement 1999;50():443-9.
1998: M Niittykoski; R Lappalainen; Jukka Jolkkonen; Antti Haapalinna; P Riekkinen; Jouni Sirviö
Systemic administration of atipamezole, a selective antagonist of alpha-2 adrenoceptors, facilitates behavioural activity but does not influence short-term or long-term memory in trimethyltin-intoxicated and control rats.
Neuroscience and biobehavioral reviews 1998;22(6):735-50.
1997: Jukka Jolkkonen; K Kähkönen; Asla Pitkänen
Cholinergic deafferentation exacerbates seizure-induced loss of somatostatin-immunoreactive neurons in the rat hippocampus.
Neuroscience 1997;80(2):401-11.
1997: Johanna Kuhmonen; J Pokorný; Riitta Miettinen; Antti Haapalinna; Jukka Jolkkonen; PJ Riekkinen; Juhani Sivenius
Neuroprotective effects of dexmedetomidine in the gerbil hippocampus after transient global ischemia.
Anesthesiology 1997;87(2):371-7.
1997: Jukka Jolkkonen; Esa Jolkkonen; Asla Pitkänen
Seizure-induced damage to somatostatin-immunoreactive neurons in the rat hippocampus is regulated by fimbria-fornix transection.
Experimental neurology 1997;145(1):141-53.
1996: Jukka Jolkkonen; Toivo Halonen; Esa Jolkkonen; Jari Nissinen; Asla Pitkänen
Seizure-induced damage to the hippocampus is prevented by modulation of the GABAergic system.
Neuroreport 1996;7(12):2031-5.
1995: Ranan Rimón; Ulla Lepola; Jukka Jolkkonen; T Halonen; PJ Riekkinen
Cerebrospinal fluid gamma-aminobutyric acid in patients with panic disorder.
Biological psychiatry 1995;38(11):737-41.
1994: Leena Tuomisto; A Yamatodani; Jukka Jolkkonen; E L Sainio; M M Airaksinen
Inhibition of brain histamine synthesis increases food intake and attenuates vasopressin response to salt loading in rats.
Methods and findings in experimental and clinical pharmacology 1994;16(5):355-9.
1993: Jukka Jolkkonen; Ulla Lepola; Garth Bissette; Charles Nemeroff; PJ Riekkinen
CSF corticotropin-releasing factor is not affected in panic disorder.
Biological psychiatry 1993;33(2):136-8.
1992: Jukka Jolkkonen; M Mazurkiewicz; H Lahtinen; PJ Riekkinen
Acute effects of gamma-vinyl GABA on the GABAergic system in rats as studied by microdialysis.
European journal of pharmacology 1992;229(2-3):269-72.
1992: Pekka Jäkälä; Jouni Sirviö; Jukka Jolkkonen; PJ Riekkinen; L Acsady; P Riekkinen
The effects of p-chlorophenylalanine-induced serotonin synthesis inhibition and muscarinic blockade on the performance of rats in a 5-choice serial reaction time task.
Behavioural brain research 1992;51(1):29-40.
1992: T Keränen; Jukka Jolkkonen; P K Jensen; G P Menge; P Andersson
Absence of interaction between oxcarbazepine and erythromycin.
Acta neurologica Scandinavica 1992;86(2):120-3.
1992: T Keränen; Jukka Jolkkonen; P Klosterskov-Jensen; G P Menge
Oxcarbazepine does not interact with cimetidine in healthy volunteers.
Acta neurologica Scandinavica 1992;85(4):239-42.
1991: Jouni Sirviö; P Riekkinen; Antti Valjakka; Jukka Jolkkonen; PJ Riekkinen
The effects of noradrenergic neurotoxin, DSP-4, on the performance of young and aged rats in spatial navigation task.
Brain research 1991;563(1-2):297-302.
1991: Jukka Jolkkonen; Päivi Hartikainen; R Soikkeli; Garth Bissette; Charles Nemeroff; PJ Riekkinen
A correlation study of CSF neuropeptides in Alzheimer's and Parkinson's disease.
Neuropeptides 1991;19(2):97-102.
1990: Hannu Koponen; K J Reinikainen; Jukka Jolkkonen; PJ Riekkinen
Somatostatin-like immunoreactivity in the CSF of patients with dementia associated with alcoholism.
Acta neurologica Scandinavica 1990;82(5):289-91.
1990: K J Reinikainen; Hannu Koponen; Jukka Jolkkonen; PJ Riekkinen
Decreased somatostatin-like immunoreactivity in the cerebrospinal fluid of chronic schizophrenic patients with cognitive impairment.
Psychiatry research 1990;33(3):307-12.
1990: Ulla Lepola; Jukka Jolkkonen; A Pitkänen; PJ Riekkinen; Ranan Rimón
Cerebrospinal fluid monoamine metabolites and neuropeptides in patients with panic disorder.
Annals of medicine 1990;22(4):237-9.
1989: Asla Pitkänen; Juha Hyttinen; Jouni Sirviö; Jukka Jolkkonen; H Sarlund; PJ Riekkinen
The levels of somatostatin in the brain and CSF of rat after carbamazepine administration.
Pharmacology & toxicology 1989;64(3):266-71.
1989: Ulla Lepola; Jukka Jolkkonen; Ranan Rimón; PJ Riekkinen
Long-term effects of alprazolam and imipramine on cerebrospinal fluid monoamine metabolites and neuropeptides in panic disorder.
Neuropsychobiology 1989;21(4):182-6.
1989: Jukka Jolkkonen; Eeva-Liisa Helkala; R Kutvonen; M Lehtinen; PJ Riekkinen
Vasopressin levels in CSF of Alzheimer patients: correlations with monoamine metabolites and neuropsychological test performance.
Psychoneuroendocrinology 1989;14(1-2):89-95.
1988: Jukka Jolkkonen; Leena Tuomisto; T B van Wimersma Greidanus; PJ Riekkinen
Vasopressin levels in the cerebrospinal fluid of rats with lesions of the paraventricular and suprachiasmatic nuclei.
Neuroscience letters 1988;86(2):184-8.
1988: Hilkka Soininen; PJ Riekkinen; Juhani Partanen; Eeva-Liisa Helkala; V Laulumaa; Jukka Jolkkonen; K Reinikainen
Cerebrospinal fluid somatostatin correlates with spectral EEG variables and with parietotemporal cognitive dysfunction in Alzheimer patients.
Neuroscience letters 1988;85(1):131-6.
1988: K J Reinikainen; PJ Riekkinen; Leo Paljärvi; Hilkka Soininen; Eeva-Liisa Helkala; Jukka Jolkkonen; Markku Laakso
Cholinergic deficit in Alzheimer's disease: a study based on CSF and autopsy data.
Neurochemical research 1988;13(2):135-46.
1988: Asla Pitkänen; Jukka Jolkkonen; Jouni Sirviö; PJ Riekkinen
Somatostatin-like immunoreactivity and somatostatin receptor binding in rat brain in pentylenetetrazol-induced kindling.
Peptides 1988;9 Suppl 1():105-7.
1988: Jouni Sirviö; Antti Valjakka; Jukka Jolkkonen; A Hervonen; PJ Riekkinen
Cholinergic enzyme activities and muscarinic binding in the cerebral cortex of rats of different age and sex.
Comparative biochemistry and physiology. C, Comparative pharmacology and toxicology 1988;90(1):245-8.
1988: Jukka Jolkkonen; Leena Tuomisto; T B Van Wimersma Greidanus; E Läärä; PJ Riekkinen
Effects of osmotic stimuli on vasopressin levels in the CSF of rats.
Peptides 1988;9 Suppl 1():109-11.
1987: Asla Pitkänen; Jukka Jolkkonen; PJ Riekkinen
Beta-endorphin, somatostatin, and prolactin levels in cerebrospinal fluid of epileptic patients after generalised convulsion.
Journal of neurology, neurosurgery, and psychiatry 1987;50(10):1294-7.
1987: Jukka Jolkkonen; Hilkka Soininen; PJ Riekkinen
beta-Endorphin-like immunoreactivity in cerebrospinal fluid of patients with Alzheimer's disease and Parkinson's disease.
Journal of the neurological sciences 1987;77(2-3):153-9.
1987: K J Reinikainen; PJ Riekkinen; Jukka Jolkkonen; V M Kosma; Hilkka Soininen
Decreased somatostatin-like immunoreactivity in cerebral cortex and cerebrospinal fluid in Alzheimer's disease.
Brain research 1987;402(1):103-8.
1986: Jukka Jolkkonen; Hilkka Soininen; Toivo Halonen; Aarne Ylinen; V Laulumaa; M Laakso; PJ Riekkinen
Somatostatin-like immunoreactivity in the cerebrospinal fluid of patients with Parkinson's disease and its relation to dementia.
Journal of neurology, neurosurgery, and psychiatry 1986;49(12):1374-7.
1986: Jukka Jolkkonen; L Tuomisto; T B van Wimersma Greidanus; E Läärä; PJ Riekkinen
Vasopressin levels in the cerebrospinal fluid in rats of different age and sex.
Neuroendocrinology 1986;44(2):163-7.
1985: Jukka Jolkkonen; Hilkka Soininen; PJ Riekkinen
The effect of ACTH4-9 analog (Org2766) on some cerebrospinal fluid parameters in patients with Alzheimer's disease.
Life sciences 1985;37(7):585-90.
1984: Hilkka Soininen; Jukka Jolkkonen; K J Reinikainen; T O Halonen; PJ Riekkinen
Reduced cholinesterase activity and somatostatin-like immunoreactivity in the cerebrospinal fluid of patients with dementia of the Alzheimer type.
Journal of the neurological sciences 1984;63(2):167-72.